Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

NCT01804634 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Refractory and/or Relapsed Metastatic Solid Tumors

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
RADIATION: low dose total body irradiation
DRUG: Melphalan
DRUG: Tacrolimus

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]